Evidence map›Paper›PMID 16705201›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2006

Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study.

M Brandt-Christensen, K Kvist, F M Nilsson, P K Andersen, L V Kessing

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Neuroticism and Risk of Parkinson's Disease: A Meta-Analysis.Movement disorders : official journal of the Movement Disorder Society · 2021
    Pooled it
  4. Use of antipsychotics and long-term risk of parkinsonism.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  5. Article
  6. Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study.Movement disorders : official journal of the Movement Disorder Society · 2010
    Article
  7. Use of antidepressants and the risk of Parkinson's disease: a prospective study.Journal of neurology, neurosurgery, and psychiatry · 2009
    Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

M Brandt-ChristensenDepartment of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, Blegdamsvej 9, DK 2100 Copenhagen, Denmark. mette.brandt@rh.dk
K Kvist
F M Nilsson
P K Andersen
L V Kessing
Copenhagen University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo estimate the risk for persons treated with antidepressants or lithium of subsequent treatment with antiparkinson drugs (APD).

methodsThe Danish national prescription database supplied data on all persons who received antidepressants, lithium, or antidiabetics (first control group). A second control group was included comprising persons from the general population. Outcome was purchase of APD and the study period was 1995 to 1999.

resultsIn total, 1 293 789 persons were included. The rate ratio of treatment with APD after treatment with antidepressants was 2.27 (95% CI 2.14 to 2.42) for men and 1.50 (95% CI 1.43 to 1.58) for women. Figures for lithium were almost identical.

conclusionPersons treated with antidepressants or lithium are at increased risk of subsequently treatment with APD, showing an association between anxiety/affective disorder and Parkinson's disease.

Indexed as

Antidepressive AgentsAntimanic AgentsAntiparkinson AgentsAnxiety DisordersCase-Control StudiesDenmarkDrug PrescriptionsEpidemiologic StudiesFemaleHumansLithium CarbonateMaleMood DisordersParkinson DiseasePharmacoepidemiologyRisk FactorsAntidepressive AgentsAntimanic AgentsAntiparkinson AgentsLithium Carbonate

Identifiers

PMID16705201
PMCPMC2077439
OpenAlexW1982843645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.